← Evidence map

ArticleCancer discovery2022

BCL10 Mutants: Architects of Oncogenic Signaling Provide a Blueprint for Precision Medicine.

James D Phelan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35929131